Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Assets Average: 2017-2024

Historic Assets Average for Akebia Therapeutics (AKBA) over the last 8 years, with Dec 2024 value amounting to $231.2 million.

  • Akebia Therapeutics' Assets Average rose 66.09% to $354.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $354.9 million, marking a year-over-year increase of 66.09%. This contributed to the annual value of $231.2 million for FY2024, which is 22.65% down from last year.
  • As of FY2024, Akebia Therapeutics' Assets Average stood at $231.2 million, which was down 22.65% from $298.9 million recorded in FY2023.
  • In the past 5 years, Akebia Therapeutics' Assets Average ranged from a high of $707.7 million in FY2020 and a low of $231.2 million during FY2024.
  • Its 3-year average for Assets Average is $324.3 million, with a median of $298.9 million in 2023.
  • Data for Akebia Therapeutics' Assets Average shows a maximum YoY slumped of 32.49% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Akebia Therapeutics' Assets Average stood at $707.7 million in 2020, then fell by 17.09% to $586.7 million in 2021, then dropped by 24.55% to $442.7 million in 2022, then slumped by 32.49% to $298.9 million in 2023, then dropped by 22.65% to $231.2 million in 2024.